BWM
CLVS

BerganKDV Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

BerganKDV Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed – – 1130
2021
Q4 		$0 Sell
50
-50
-50% -$185 ﹤0.01% 1146
2021
Q3 		$0 Hold
100
– – ﹤0.01% 1114
2021
Q2 		$1K Buy
+100
New +$586 ﹤0.01% 969
2020
Q4 		– Sell
-100
Closed -$1K – 1029
2020
Q3 		$1K Sell
100
-14,055
-99% -$84.1K ﹤0.01% 888
2020
Q2 		$96K Buy
14,155
+10,512
+289% +$79.6K 0.02% 281
2020
Q1 		$23K Buy
+3,643
New +$29.2K ﹤0.01% 409

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

BerganKDV Wealth Management's CLVS Position: Q1 2022 in Review

BerganKDV Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 50 shares.

BerganKDV Wealth Management first reported a position in CLVS in Q1 2020 and held it in 6 quarters. The position peaked at $96K in Q2 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • BerganKDV Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • BerganKDV Wealth Management sold 50 Clovis Oncology, Inc. shares in Q1 2022.
  • BerganKDV Wealth Management first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 6 quarters.
  • BerganKDV Wealth Management's Clovis Oncology, Inc. position peaked at $96K in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on BerganKDV Wealth Management's 13F filing for Q1 2022, filed 9 May 2022.